Heme and nonheme-type flavone synthase enzymes, FS I and FS II are responsible for the synthesis of flavones, which play an important role in various biological processes, and have a wide range of biomedicinal properties including antitumor, antimalarial, and antioxidant activities. To get more insight into the mechanism of this curious enzyme reaction, nonheme structural and functional models were carried out by the use of mononuclear iron, [FeII(CDA-BPA*)]2+ (6) [CDA-BPA = N,N,N',N'-tetrakis-(2-pyridylmethyl)-cyclohexanediamine], [FeII(CDA-BQA*)]2+ (5) [CDA-BQA = N,N,N',N'-tetrakis-(2-quinolilmethyl)-cyclohexanediamine], [FeII(Bn-TPEN)(CH3CN)]2+ (3) [Bn-TPEN = N-benzyl-N,N',N'-tris(2-pyridylmethyl)-1,2-diaminoethane], [FeIV(O)(Bn-TPEN)]2+ (9), and manganese, [MnII(N4Py*)(CH3CN)]2+ (2) [N4Py* = N,N-bis(2-pyridylmethyl)-1,2-di(2-pyridyl)ethylamine)], [MnII(Bn-TPEN)(CH3CN)]2+ (4) complexes as catalysts, where the possible reactive intermediates, high-valent FeIV(O) and MnIV(O) are known and well characterised. The results of the catalytic and stoichiometric reactions showed that the ligand framework and the nature of the metal cofactor significantly influenced the reactivity of the catalyst and its intermediate. Comparing the reactions of [FeIV(O)(Bn-TPEN)]2+ (9) and [MnIV(O)(Bn-TPEN)]2+ (10) towards flavanone under the same conditions, a 3.5-fold difference in reaction rate was observed in favor of iron, and this value is three orders of magnitude higher than was observed for the previously published [FeIV(O)(N2Py2Q*)]2+ [N,N-bis(2-quinolylmethyl)-1,2-di(2-pyridyl)ethylamine] species.
Heme and nonheme-type flavone synthase enzymes, FS I and FS II are responsible for the synthesis of flavones, which play an important role in various biological processes, and have a wide range of biomedicinal properties including antitumor, antimalarial, and antioxidant activities. To get more insight into the mechanism of this curious enzyme reaction, nonheme structural and functional models were carried out by the use of mononuclear iron, [FeII(CDA-BPA*)]2+ (6) [CDA-BPA = N,N,N',N'-tetrakis-(2-pyridylmethyl)-cyclohexanediamine], [FeII(CDA-BQA*)]2+ (5) [CDA-BQA = N,N,N',N'-tetrakis-(2-quinolilmethyl)-cyclohexanediamine], [FeII(Bn-TPEN)(CH3CN)]2+ (3) [Bn-TPEN = N-benzyl-N,N',N'-tris(2-pyridylmethyl)-1,2-diaminoethane], [FeIV(O)(Bn-TPEN)]2+ (9), and manganese, [MnII(N4Py*)(CH3CN)]2+ (2) [N4Py* = N,N-bis(2-pyridylmethyl)-1,2-di(2-pyridyl)ethylamine)], [MnII(Bn-TPEN)(CH3CN)]2+ (4) complexes as catalysts, where the possible reactive intermediates, high-valent FeIV(O) and MnIV(O) are known and well characterised. The results of the catalytic and stoichiometric reactions showed that the ligand framework and the nature of the metalcofactor significantly influenced the reactivity of the catalyst and its intermediate. Comparing the reactions of [FeIV(O)(Bn-TPEN)]2+ (9) and [MnIV(O)(Bn-TPEN)]2+ (10) towards flavanone under the same conditions, a 3.5-fold difference in reaction rate was observed in favor of iron, and this value is three orders of magnitude higher than was observed for the previously published [FeIV(O)(N2Py2Q*)]2+ [N,N-bis(2-quinolylmethyl)-1,2-di(2-pyridyl)ethylamine] species.
Flavones are low molecular weight phytochemicals that play an important role in various biological processes and have a positive impact on our health [1]. Due to their wide range of biological activities (malaria, anti-cancer, anti-diabetes, asthma, antiviral, antioxidant, anti-microbial, anti-ulcer, anti-inflammation, cardiovascular activity, neuroprotection, etc.) their syntheses have become important goals of medicinal and bioorganicchemists [2,3,4,5,6,7,8]. Flavonescan be synthesised by various methods including Baker-Venkataraman-rearrangement from o-hydroxyacetophenone [1], and oxidation of flavanones using various stoichiometric reagents such as DMSO/I2 [9], SeO2 [10], 2,3-dichloro-5,6-dicyano-1,4-benzoquinone [11], thallium salts [12] and manganese acetate [13]. The oxidation of flavanones by heme and nonhemeiron-dependent enzymes is one of the most important steps during the biosynthesis of flavones. High-valent oxoiron(IV) intermediates as key oxidants are well-established in both heme and nonheme enzymes, including cytochrome P450, bovine liver catalase (BLC) [14,15], flavone synthase II (FS II) [16,17,18,19,20], pterin-dependent phenylalanine hydroxylase [21], and α-keto acid-dependent dioxygenases (taurine dioxygenase, TauD [22,23,24] and flavone synthase I, FS I) [25,26,27,28], and their synthetic biomimetic models. Interestingly, two main classes of flavone synthase enzymes are known, FS I and FS II, with totally different active sites and catalytic mechanisms (Scheme 1). The majority of flavone synthase enzymes (FS II) contain iron(III)-protoporphyrin (PFeIII) as a prosthetic group with (P+•)FeIV=O oxidant (CYP93B), and the reaction proceeds via the formation of 2-hydroxyflavanone (monooxygenase activity) and its subsequent dehydration into the flavones [29]. In contrast, FS I enzymes utilise nonheme mononuclear iron(II)-2-oxoglutarate (FeII/2-OG) as a prosthetic group where the reaction can be described by oxoiron(IV) mediated, direct non-concerted 2,3-desaturation without 2-hydroxyflavanone formation [30].
Scheme 1
Oxidation of flavanone by heme and nonheme flavone synthases, FS I and FS II.
Since flavanone itself is a chiral molecule, oxidative kinetic resolution (OKR) of racemicflavanonescan also be performed with a chiral ironcatalyst and oxoiron(IV) intermediates. Increasing interest in the region and stereoselective metal-based reactions to generate new stereogeniccentres in a highly diastereoselective and/or enantioselective fashion inspires the search for biomimetic oxidation catalysts. Intermediates of this type were observed in catalytic oxidation systems and synthetised and identified indirectly by the use of iron precursor complexes with various chiral and achiral aminopyridine ligands [31,32,33,34,35,36].In the present work, we carried out stoichiometric and catalyticflavanone oxidation reactions with spectroscopically well-characterised nonhemeoxoiron(IV) intermediates compared to their analogous oxomanganese(IV) compounds, [FeIV(O)(Bn-TPEN)]2+ (9) [37,38], [FeIV(O)(CDA-BPA)]2+ (11), [MnIV(O)(N4Py*)]2+ (8) [39], [MnIV(O)(Bn-TPEN)]2+ (10) [40] and their precursor complexes, [FeII(Bn-TPEN)(CH3CN)]2+ (3), [FeII(CDA-BQA*)]2+ (5), [FeII(CDA-BPA*)]2+ (6) [41], [MnII(N4Py*)(CH3CN)]2+ (2) [39], [MnII(Bn-TPEN)(CH3CN)]2+ (4) (Scheme 2) [40]. To the best of our knowledge, this study provides the first mechanistic details of oxomanganese(IV)-mediated flavanone oxidation compared to their analogous oxoiron(IV)-mediated systems, which may serve as a functional model of FS enzymes. Based on the detected intermediary products, the catalysis of double-bond formation is suggested to take place in two steps, namely by the monohydroxylation of the substrate, and then the elimination of water from the intermediary 2-hydroxyflavanone. This mechanism is different from the hitherto known FS I enzyme, but it is consistent with other 2-oxoglutarate-dependent enzymes, and the hemeiron-dependent flavone synthase II.
Scheme 2
Oxoiron(IV) and oxomanganese(IV) complexes with their iron(II) and manganese(II) precursor complexes were used in this study.
2. Results and Discussion
2.1. Nonheme Iron and Manganese-Containing Biomimics of the Flavone Synthase Enzyme
The use of well-chosen ligands made it possible to prepare, spectroscopically characterise, and study the reactivity of the putative intermediates in enzymatic processes. In the last 20 years, a number of precursor iron(II)complexes with their high-valent oxoiron(IV) intermediates have been prepared by the use of multidentate N-donor ligands such as TPA, N4Py, Py5 [2,6-(bis-(bis-2-pyridyl)methoxymethane)pyridine] and TPEN (N,′-tetrakis(2-pyridylmethyl)- ethylenediamine) [37,38,39,40,41,42]. These complexes as catalysts and/or intermediates catalyse all types of oxidation reactions such as epoxidations, heteroatom oxidations, and even C-H oxidations including hydrogen-atom transfer (HAT) and oxygen-atom transfer (OAT) [43,44,45].The primary aspect of ligand selection, as a continuation of our previous work, was to increase the reactivity of the catalyst and its intermediates towards flavanone [46]. For this purpose, new ([FeII(CDA-BQA*)]2+ (5), [FeIV(O)(CDA-BPA*)]2+ (11)) and spectroscopically well-characterised ([FeII(CDA-BPA*)]2+ (6), [FeII(Bn-TPEN)(CH3CN)]2+ (3) [FeIV(O)(Bn-TPEN)]2+ (9)) nonhemeiron(II) and oxoiron(IV) complexes, were chosen. Since nonheme oxomanganese (IV) complexes have proven to be versatile oxidants [40], in addition to iron-containing models we also aimed to elucidate the role of the metalcofactor through the comparison of well-defined iron- and manganese-containing systems. Previously reported [MnII(N4Py*)(CH3CN)]2+ (2), [MnII(Bn-TPEN)(CH3CN)]2+ (4) as catalysts and [MnIV(O)(N4Py*)]2+ (8), [MnIV(O)(Bn-TPEN)]2+ (10) as possible intermediates in the oxidation reactions were chosen for these measurements [39,40]. In this work, catalytic oxidation of flavanone was performed with 2, 3, 4, 5, and 6. Catalytic oxidation of ethylbenzene was performed with 5 and 6, and stoichiometric oxidation reactions were performed with 7, 8, 9, 10, and 11. N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) is a well-known metalchelator. TPENcomplexes are often used as Zn(II) and Cd(II) indicators, and in this case, substituting the pyridine for quinoline results in enhancement of fluorescence intensity and use of these ligands as fluorescent probes [47,48]. Fe(II)complexes of the TPEN group of ligands have interesting electronical properties, where conformational changes are linked to different spin-state interconversion processes [41]. Due to the interesting redox behaviour of these Fe(II)complexes they have been studied as superoxide dismutase mimics [49] and for their reactivity towards hydrogen peroxide [50].In this work, a single-crystal structure was obtained for the complex [FeII(±CDA-BQA)](CF3SO3)2 (5). The complex was prepared with the racemic version of ligand CDA-BQA*. In the CSD database, there are 29 structures of Fe(II)complexes of these types of ligands, with four pyridyl or quinoline groups connected by an ethylenediamine or cyclohexanediamine linker [51,52]. The only reported Fe(II)complex with a cyclohexanediamine linker is [FeII(CDA-BPA*)](ClO4)2 (6) (CSD refcode YAMXAL) [41] The geometry of the newly synthesised [FeII(CDA-BQA*)](CF3SO3)2 (5) (Figure 1) and [FeII(CDA-BPA*)](ClO4)2 (6) is compared in Figure 2 and Table 1. Both complexes are prepared with racemic ligands, however, 5 crystallised as a racemate, while 6 has spontaneously resolved into its optical isomers, containing only the (R,R) enantiomer. While complex 6 has a regular octahedral geometry, the Fe-N bonds in 5 are elongated, forming a pentagonal bipyramidal geometry with an equatorial vacancy, as determined using the program FindGeo [53]. The reason for this is likely the stericcrowding of the quinoline groups in 5. The significantly longer Fe-N bond lengths (>2.2 Å) are in agreement with a high spin Fe(II)centre in 5. The UV-Vis spectrum of 5 in acetonitrile is dominated by the intense π-π* band at 307 nm (=12,800 M−1 cm−1), and an additional broad feature of low intensity between 330 and 460 nm (λmax = 356 with ε = 2080 M−1 cm−1) can be assigned to an MLCT transition. The weak intensity is consistent with the high spin state of the iron(II)centre [46].
Figure 1
X-ray structure of FeII(±CDA-BQA*)](CF3SO3)2 (5), showing a 30% probability of thermal ellipsoids.
Figure 2
Overlay of structures FeII(CDA-BQA*)](CF3SO3)2 (5) (red) and [FeII(CDA-BPA*)](ClO4)2 (6) (blue) containing only (R,R)-enantiomers of the ligands.
Table 1
Selected bond lengths of complex [FeII(±CDA-BQA*)](CF3SO3)2 (5) compared to the literature example of [FeII(CDA-BPA*)](ClO4)2 (6) complex. The geometry was determined using the program FindGeo [53].
Fe-N1/Å
Fe-N2/Å
Fe-N3/Å
Geometry/RMSD/Å
[FeII(±CDA-BQA*)](CF3SO3)2 (5)
2.194
2.238
2.252
Pentagonal bipyramid with a vacancy (equatorial) (regular)0.271
[FeII(CDA-BPA*)](ClO4)2 (6) [41]
1.9932.003
2.0122.038
1.9941.993
Octahedron (regular)0.369
2.2. Catalytic Oxidation Reactions
The catalytic activities of the three ferrous and two manganesecomplexes [FeII(Bn-TPEN)(CH3CN)]2+ (3), [FeII(CDA-BQA*)]2+ (5), [FeII(CDA-BPA*)]2+ (6), [MnII(N4Py*)(CH3CN)]2+ (2) and [MnII(Bn-TPEN)(CH3CN)]2+ (4) were studied in the oxidation of flavanone, utilising mCPBA (meta-chloroperoxybenzoic acid) as the co-oxidant. The oxidation reactions were carried out under standard catalyticconditions (5:100:500 ratio for the catalyst:substrate:oxidant) in acetonitrile at room temperature (Table 2 and Figure 3). Similarly to our previous results, it took less than 10 min to have about 30–36% and 19–24% yields (based on the substrate) for the iron(II)- and manganese(II)-catalysed reactions, respectively. Much lower yields (0.36 and 2.8%) were observed for the Fe(ClO4)2 and Mn(ClO4)2 salts, respectively. Both the iron(II) and manganese(II)-catalysed oxidations of flavanone produced flavones (F) as a major product in all cases in addition to two minor products, namely 2-hydroxy-2-phenyl-chroman-4-one (A, 2-hydroxy-flavanone) and its open tautomeric form 1-(2-hydroxy-phenyl)-3-phenyl-propane-1,3-dione (D). It was found earlier [46] that complex 1 together with mCPBA oxidizes flavanone, and a turnover number (TON) of 6.93 for F, 0.11 for D and 0.02 for A was obtained with an overall yield of 9.42%. Its manganese analogue produced an overall yield of 18.8%, TON for F = 3.58, TON for D = 0.19 and TON for A = ~0.01.
Table 2
Catalytic oxidation of flavanone (FH2) carried out by 2, 3, 4, 5 and 6 with mCPBA in CH3CN at 25 °C.
MII
[H2O]/mM
[MII]/mM
[FH2]/mM
[mCPBA]/mM
Yield (F)/%
TON
Yield (D) c/%
TON
Yieldt/%
[FeII(CDA-BPA*)]2+(6)
44
5
100
500
35.2
7.04
1.15
0.23
36.35
[FeII(Bn-TPEN)]2+(3)
44
5
100
500
29
5.8
1.4
0.28
30.4
[FeII(CDA-BQA*)]2+(5)
44
5
100
500
20.8
4.16
0.83
0.17
21.63
[MnII(N4Py*)]2+(2)
44
5
100
500
17.9
3.58
0.92
0.19
18.8
[MnII(N4Py*)]2+(2)
55
5
100
500
15.7
3.14
1.2
0.23
16.9
[MnII(N4Py*)]2+(2)
65
5
100
500
13.8
2.76
1.45
0.3
15.25
[MnII(N4Py*)]2+(2)
75
5
100
500
12.2
2.44
2.4
0.48
14.64
[MnII(N4Py*)]2+(2)
85
5
100
500
10.7
2.14
3.2
0.64
13.9
[MnII(N4Py*)]2+(2)
95
5
100
500
9
1.88
4.2
0.92
13.2
[MnII(N4Py*)]2+(2)
44
5
100 a
500
16.8 a
3.36
1.1
0.2
17.9
[MnII(N4Py*)]2+(2)
44
5
100 b
500
11.2 b
2.24
1.8
0.36
12.95
[MnII(Bn-TPEN)]2+(4)
44
5
100
500
23.1
4.62
0.61
0.12
23.7
a In the presence of 2,6-di-tert-butylphenol (2,6-DTBP), [2,6-DTBP] = 25 mM. b In the presence of 2,6-di-tert-butylphenol (2,6-DTBP), [2,6-DTBP] = 60 mM.c Yield of A is less than 0.1%.
Figure 3
Comparison of the flavones-synthase activity of iron(II) and manganese(II) complexes. Conditions: [MII] = 5 mM, [FH2] = 100 mM and [mCPBA] = 500 mM in CH3CN at 25 °C.
It is important to mention that the amount of 1,3-dione (D) can be increased from 0.92% (TON = 0.19) to 4.2% (TON = 0.92) in the presence of H2O, suggesting an equilibrium step during the flavone formation (Figure 4B). However, when 2,6-di-tert-butylphenol (DTBP) was added significantly less flavanone was converted, suggesting a free-radical type mechanism as a parallel process of the metal-based oxidation (Figure 4A). Significantly higher yields were observed for 3 (30.4%, TON for F = 5.80, TON for D = 0.28), 5 (21.6%, TON for F = 4.16, TON for D = 0.17), 6 (36.35%, TON for F = 7.04, TON for D = 0.23) and 4, suggesting clearly that the ligand framework and the nature of the metal influenced the catalytic activities of these complexes. The relative reactivities of iron(II) and manganese(II)complexes are in the order of [FeII(CDA-BPA*)]2+ (6) > [FeII(Bn-TPEN)(CH3CN)]2+ (3) > [MnII(Bn-TPEN)(CH3CN)]2+ (4) > [FeII(CDA-BQA*)]2+ (5) > [MnII(N4Py*)(CH3CN)]2+ (2) > [FeII(N4Py*)(CH3CN)]2+ (1). It should be underlined that the presence of both the theoretical tautomers (A and D) of the acid-labile intermediate of flavone strongly supports the hypothesis that flavone biosynthesis proceeds via 2-hydroxylation of flavanone. A similar mechanism was proposed for the cytochrome P450 monooxygenase (FS II) and other 2-oxoglutarate-dependent dioxygenases.
Figure 4
(A) Comparison of the product formation in the [MnII(N4Py*)(CH3CN)]2+ (2) catalysed oxidation of flavanone with mCPBA as co-oxidant and 2,6-DTBP as a radical trapping agent. (B) Comparison of the product formation in the presence of added water.
Recently, chiral N4Py-type and L-proline derived aminopyridinecontaining oxoiron(IV) complexes were reported which could perform enantioselective oxidation of various substrates such as thioanisole, hydrocarbons, alkenes and substituted cyclohexanones [31,33]. To the best of our knowledge, these are the first examples of chiral nonhemeoxoiron(IV) complexes tested in asymmetricC-H hydroxylation reactions. Since flavanone is a chiral molecule including benzylicC-H bonds, oxidative kinetic resolution (OKR) of racemicflavanonescan in principle also be performed with a chiral ironcatalyst and oxoiron(IV) intermediates. The oxidation of ethylbenzene that can be used as a model compound of flavanone, by chiral [FeIV(O)(N4Py*)]2+ (7) species showed moderate enantioselectivities up to 33% ee as a result of a non-rebound mechanism including the epimerization of the long-lived alkyl radical before the rebound step [36]. To increase the enantioselectivity, we also examined the enantioselectivity of the [FeII(CDA-BPA*)]2+ (6) catalyst and the in situ generated [FeIV(O)(CDA-BPA*)]2+ (11) intermediate from 6 and PhIO in the asymmetricC-H hydroxylation of ethylbenzene utilizing TBHP and PhIO as co-oxidants (Figure 5 and Table 3). In these probe reactions, moderate enantioselective hydroxylation could be obtained in all cases, so the studies on oxidative kinetic resolution of racemicflavanones were discarded.
Figure 5
Dependence of the K/A ratio and the enantiomeric excess (ee%) on the oxidant concentration for the [FeII(CDA-BPA*)]2+ (6) catalysed oxidation of ethylbenzene with TBHP in CH3CN at 0 °C.
Table 3
Catalytic oxidation of ethylbenzene carried out by (R,R)-(−)-6 and (R,R)-(−)-5 with various co-oxidants a.
[6]:[PhEt]:[Co-oxidant]
TON (A) b
TON (K) c
Yield/% d
K/A
ee/%
2:500:50 (TBHP)
1.38
2.83
16.84
2.05
7.25 (R)
2:500:100 (TBHP)
1.82
5.20
14.04
2.86
4.13 (R)
2:500:200 (TBHP)
2.06
6.17
8.23
3.00
2.68 (R)
2:1500:16 (PhIO)
0.96
2.14
38.75
2.23
12.21 (R)
[5]:[PhEt]:[Co-oxidant]
TON (A b)
TON (K c)
Yield/% d
K/A
ee/%
2:500:100 (TBHP)
-
10.08
20.16
-
-
a Reaction conditions: see Experimental section. b 1-Phenylethanol. c Acetophenone. d Based on oxidant.
2.3. Stoichiometric Oxidation Reactions
We have previously reported for a family of aminopyridinecontaining oxoiron(IV) complexes, FeIV(O)(N4Py) [N4Py = N,N’-bis(2-pyridylmethyl)-N-bis(2-pyridyl)methylamine], FeIV(O)(TPA) [TPA = tris(2-pyridylmethyl)amine] that the reactivity in HAT and OAT reactions can be significantly enhanced by the introduction of 6-substituents on the pyridine rings (TPA), or by the replacement of one or more pyridyl arms of TPA, N4Py or N4Py* with quinolyl arms, despite their thermal stabilities [46,54,55]. Modification of the N4Py ligand as described above resulted in the following reaction rate orders for the flavanone oxidation: [FeIV(O)(N2Py2Q*)]2+ > [FeIV(O)(N4Py)]2+ > [FeIV(O)(N4Py*)]2+ (Table 4), where the most reactive complex reacts 80-fold faster than the slowest one [46]. The stability and reactivity of the complexes are also greatly influenced by the number of nitrogen-donor atoms and their hybrid state. For example the oxidation of ethylbenzene by pentadentate [FeIV(O)(Bn-TPEN)]2+ (9) complex with two N(sp3) and 3 N(sp2) donor atoms react 20-fold faster than that of [FeIV(O)(N4Py)]2+ [37]. Taking these results into account, further studies were performed using the previously published [FeIV(O)(Bn-TPEN)]2+ (9) and the newly synthetised FeIV(O)(CDA-BPA)]2+ (11) complexes for the stoichiometric oxidation of flavanone. Complexes 9 and 11 could be generated from their iron(II) precursor complexes by literature methods using 2 equiv solid PhIO for 30–40 min [37,38]. The reaction of 6 with PhIO in acetonitrile at room temperature results in a green species (11), characterised by a characteristic absorption band at 740 nm (ε ≈ 450 M−1 cm−1), which can be assigned as a ligand-field (d-d) transition on the low-spin (S = 1) Fe(IV) centre. This species is much less stable (t1/2 ≈ 2 h at 25 °C) than that was found for 9 (t1/2 ≈ 6 h at 25 °C). Their decay can be significantly enhanced by the addition of flavanone.
Table 4
Rate constants and activation parameters for the oxidation of flavanone with oxometal(IV) complexes.
Complex
103k2/s−1 M−1
ΔH‡/kJ mol−1
ΔS‡/J mol−1 K−1
ΔG‡/kJ mol−1
Solvent/T
Refs.
[FeIV(O)(N4Py*)]2+ (7)
0.24 ± 0.01
70 ± 3
−75 ± 9
92.2
CH3CN (25 °C)
[46]
[FeIV(O)(N4Py)]2+
0.57 ± 0.03
63 ± 4
−93 ± 13
90.9
CH3CN (25 °C)
[46]
[FeIV(O)(N2Py2Q*)]2+
19.2 ± 1.1
48 ± 2
−121 ± 8
83.7
CH3CN (25 °C)
[46]
[FeIV(O)(N2Py2Q*)]2+
6.50 ± 0.32
CH3CN (10 °C)
[46]
[FeIV(O)(Bn-TPEN)]2+ (9)
1340 ± 67
28 ± 2
−150 ± 8
72.7
CH3CN (25 °C)
This work
[FeIV(O)(Bn-TPEN)]2+ (9)
680 ± 27
CH3CN (10 °C)
This work
[FeIV(O)(Bn-TPEN)]2+ (9)
1520 ± 90
CH3CN/TFE (10 °C)
This work
[FeIV(O)(CDA-BPA*)]2+ (11)
970 ± 40
CH3CN (10 °C)
This work
[MnIV(O)(N4Py*)]2+ (8)
0.58 ± 0.03
CH3CN/TFE (25 °C)
This work
[MnIV(O)(Bn-TPEN)]2+ (10)
420 ± 15
43 ± 3
−114 ± 10
76.7
CH3CN/TFE (10 °C)
This work
The detailed kinetic measurements were carried out in CH3CN and CH3CN/CF3CH2OH (TFE) = 1:1 solutions at 10–25 °C, and the decay of the oxoiron(IV) species 9 and 11 during the flavanone oxidation was followed as a decrease in absorbance at ~740 nm (Figure 6 and Tables S2–S5). The yields of flavone were around ~80% for both complexes. The reaction rates in the presence of 10–50 times excess of substrate obeyed pseudo-first-order kinetics, and the pseudo-first-order rate constants (kobs) were directly proportional to the concentration of flavanone, from which the reaction rate constants (k2) are 0.68 ± 0.027 M−1 s−1 and 0.97 ± 0.04 M−1 s−1 for 9 and 11 at 10 °C, respectively (Figure 7 and Table 4). These values are three orders of magnitude higher than those observed for the previously published [FeIV(O)(N2Py2Q*)]2+ species [46], showing clearly that the ligand framework significantly influenced the reactivity of the oxoiron(IV) species.
Figure 6
(A) UV-Vis spectral changes of 9 (2 mM, red line) upon addition of flavanone (50 mM) in CH3CN at 10 °C. The inset shows the time course of the decay of 9 monitored at 739 nm. (B) UV-Vis spectral changes of 11 (2 mM, red line) upon addition of flavanone (50 mM) in CH3CN at 10 °C. The inset shows the time course of the decay of 11 monitored at 742 nm.
Figure 7
(A) Determination and comparison of second-order rate constants by plotting kobs values against flavanone concentration for a series of MIV(O) complexes in CH3CN at 10 °C, [M]0 = 2 mM. (B) Eyring plots of log k/T versus 1/T for 9 and 10, [9,10] = 2 mM, [FH2] = 50 mM.
The relative reactivity of oxoiron(IV) complexes is in the order of [FeIV(O)(CDA-BPA*)]2+ (11) > [FeIV(O)(Bn-TPEN)]2+ (9) > [FeIV(O)(N2Py2Q*)]2+ > [FeIV(O)(N4Py)]2+ > [FeIV(O)(N4Py*)]2+ (7), which is consistent with our catalytic results. Based on the temperature dependence of the reactivity of 9 (with ΔH‡ = 28 ± 2 kJ mol−1, ΔS‡ = −150 ± 8 J mol−1 K−1, ΔG‡ = 72.7 kJ mol−1), the value of -TΔS‡ determined was bigger than ΔH‡, indicating an entropy-controlled reaction, contrary to the previously reported enthalpy-controlled reactions with N4Py-type ligands. As a result of a compensation effect increasing activation, enthalpies are offset by increasingly positive entropies yielding ΔH‡ = 114 kJ mol−1 at the intercept (Figure 8A). The experimentally determined difference between ΔG‡ values is 20 kJ mol−1, which is significant and consistent with the observed reaction rate order (Figure 8B).
Figure 8
(A) Isokinetic plot and (B) plot of ΔG‡ versus lnk2 for the oxidation of flavanone with various oxomanganese(IV) and oxoiron(IV) complexes.
To elucidate the role of the metalcofactor, such manganese and ironcontaining systems have been chosen from the literature where the structure of the high valent metal oxo intermediates are already known. Our choice fell on the [MnIV(O)(N4Py*)]2+ (8) and [MnIV(O)(Bn-TPEN)]2+ (10) complexes. These intermediates can be generated in TFE and TFE/CH3CN by the use of PhIO as an oxidant, and the oxidation of flavanonecan be investigated following their decrease in absorbances at 944 nm (8) and 1040 nm (10), respectively (Figure 9A).
Figure 9
(A) UV-Vis spectral changes of 8 (2 mM, red line) upon addition of flavanone (1.8 M) in CH3CN/TFE at 25 °C. The inset shows the time nd course of the decay of 8 monitored at 944 nm. (B) Determination and comparison of second-order rate constants by plotting kobs values against flavanone concentration for complexes 7 and 8 in CH3CN and CH3CN/TFE at 25 °C, [M]0 = 2 mM.
Due to the correct comparison of the iron and manganese-containing system, we first investigated the effect of the solvent on the reaction rate. The reaction of [FeIV(O)(Bn-TPEN)]2+ (9) with flavanone in CH3CN/TFE (1:1) resulted in a 2-fold increase in rate, which is not considered significant. Considering the solvent effect, almost the same reaction rate was observed for the [FeIV(O)(N4Py*)]2+ (7) and [MnIV(O)(N4Py*)]2+ (8) complexes with k2 = 0.24(1) × 10−3 M−1 s−1 and k2 = 0.58(3) × 10−3 M−1 s−1 at 25 °C, respectively (Figure 9B). Comparing the reactions of [FeIV(O)(Bn-TPEN)]2+ (9) and [MnIV(O)(Bn-TPEN)]2+ (10) under the same conditions, a 3.5-fold difference in reaction rate was observed in favour of iron (Table 4 and Figure 7)). The difference in reaction rates and yields of products (~80% flavone for 9 and ~40% flavone for 10 based on the complex concentration) can be explained by a different mechanism based on the literature data. While in the case of oxoiron(IV) complexes the reactions occur mostly via an oxygen-rebound mechanism [56], in the case of manganese the process involving C-H activation can be described mainly by a non-rebound mechanism with a smaller reaction rate (Scheme 3) [40].
Scheme 3
Proposed mechanism for the C-H activation by oxoiron and oxomanganese complexes.
3. Materials and Methods
Reactions were carried out in ordinary glassware and chemicals were used as purchased from commercial suppliers without further purification. GC analyses were performed on an Agilent 6850 gas chromatograph equipped with a flame ionization detector and a 30 m SUPELCO BETA DEX225 (CHIRASIL-L-VAL) (Sigma-Aldrich, Budapest, Hungary) column. ESI-MS samples were analysed using a triple quadruple Micromass Quattro spectrometer (Waters, Milford, MA, USA) and an HPLC-MS system (Agilent Technologies 1200, Budapest, Hungary) coupled with a 6410 Triple-Quadrupole mass spectrometer, operating in a positive ESI mode. Synthesis of the ligand was carried out in a microwave reactor (CEM Discover), (CEM Inc, Scottsdale, AZ, USA) monitored by TLC on aluminium oxide 60 F254 neutral plates and detected with a UV lamp (254 nm). NMR spectra were obtained on a Bruker Avance 300 (Bruker Biospin AG, Fällanden, Switzerland) or 600 spectrometers, operating at 300 or 600 MHz for 1H and 75 or 150 MHz for 13C. The spectra are recorded at room temperature. Chemical shifts, δ (ppm), indicate a downfield shift from the residual solvent signal (δ: 1.94 ppm, δ: 118.26 ppm for CD3CN and δ: 7.26 ppm, δ: 77.16 ppm for CDCl3). Coupling constants, J, are given in Hz. The syntheses of most of the complexes used in this study have been previously reported: these complexes and the corresponding references are listed as follows: [FeII(Bn-TPEN)(CH3CN)]2+ (3), [FeIV(O)(Bn-TPEN)]2+ (9) [37,38], [MnII(Bn-TPEN)(CH3CN)]2+ (4), [MnIV(O)(Bn-TPEN)]2+ (10) [40], [MnII(N4Py*)(CH3CN)]2+ (2), [MnIV(O)(N4Py*)]2+ (8) [39], [FeII(CDA-BPA*)]2+ (6) [41].Synthesis of ligands CDA-BPA* and CDA-BQA*. The synthesis was performed according to a modified previously reported procedure [47]. The amine (1 eq.), K2CO3 (12 eq.), 2-(chloromethyl)pyridine hydrochloride or 2-(chloromethyl)quinoline hydrochloride (4 eq.) and KI (1 eq.) were suspended in 50 mL of acetonitrile. The reaction mixture was heated in a microwave reactor (50 W, reflux) for 1 h. The solvent was evaporated in a vacuum, the residue suspended in ethyl acetate and washed three times with brine and saturated NaHCO3, the organic layer dried over anhydrous sodium sulphate, filtered and evaporated in a vacuum. The crude ligand was purified by automated flash chromatography on a pre-packed neutral aluminacolumn (48 g).±CDA-BPA: (±)-trans-1,2-Diaminocyclohexane (120.0 μL, 1.0 mmol), K2CO3 (1658.4 mg, 12.0 mmol), 2-(chloromethyl)pyridine hydrochloride (656.2 mg, 4.0 mmol), KI (166.0 mg, 1.0 mmol). Automated flash chromatography 0→5% dichloromethane in methanol (Rf = 0.42, 5% dichloromethane in methanol). Yield: 303.0 mg (0.6 mmol, 63%), brown oil.(R,R)-CDA-BPA: (1R,2R)-(−)-1,2-Diaminocyclohexane (114.2 mg, 1.0 mmol), K2CO3 (1658.4 mg, 12.0 mmol), 2-(chloromethyl)pyridine hydrochloride (656.2 mg, 4.0 mmol), KI (166.0 mg, 1.0 mmol). Automated flash chromatography 0→5% dichloromethane in methanol. Yield: 337.5 mg (0.7 mmol, 71%), light brown powder. 1HNMR (300 MHz, CD3CN) δ: 8.39 (d, J = 4.7 Hz, 4H), 7.61 (d, J = 7.8 Hz, 4H), 7.55–7.41 (m, 4H), 7.18–7.03 (m, 4H), 3.70 (d, J = 14.3 Hz, 4H), 3.58 (d, J = 14.3 Hz, 4H), 2.85–2.66 (m, 2H), 1.79–1.61 (m, 2H), 1.36–1.23 (m, 1H), 1.23–1.00 (m, 4H), 0.96–0.79 (m, 1H). 13CNMR (75 MHz, CD3CN) δ: 161.6, 149.5, 136.7, 124.5, 122.6, 60.8, 56.5, 26.8, 25.7. ESI-MS (m/z): 479.2 (M + H+, 100%).±CDA-BQA: (±)-trans-1,2-Diaminocyclohexane (70.5 μL, 0.6 mmol), K2CO3 (970.2 mg, 7.0 mmol), 2-(chloromethyl)quinoline hydrochloride (500.0 mg, 2.3 mmol), KI (96.3 mg, 0.6 mmol). No further purification was required, (Rf = 0.28, ethyl acetate:hexane 1:1). Yield: 372.3 mg (0.5 mmol, 94%), yellow powder.(R,R)-CDA-BQA: (1R,2R)-(−)-1,2-Diaminocyclohexane (44.5 mg, 0.4 mmol), K2CO3 (651.6 mg, 4.7 mmol), 2-(chloromethyl)quinoline hydrochloride (378.9 mg, 1.6 mmol), KI (64.7 mg, 0.4 mmol). Automated flash chromatography 10→40% ethyl acetate in hexane. Yield: 202.3 mg (0.3 mmol, 76%), light yellow powder. 1HNMR (300 MHz, CDCl3) δ: 7.99 (d, J = 8.3 Hz, 4H), 7.91 (d, J = 8.5 Hz, 4H), 7.77 (d, J = 8.5 Hz, 4H), 7.72–7.59 (m, 8H), 7.52–7.41 (m, 4H), 4.01 (d, J = 14.1 Hz, 4H), 3.85 (d, J = 14.1 Hz, 4H), 3.00–2.81 (m, 2H), 2.49–2.27 (m, 2H), 1.88–1.69 (m, 2H), 1.25–0.94 (m, 4H). 13CNMR (75 MHz, CDCl3) δ: 161.3, 147.7, 135.8, 129.3, 129.1, 127.6, 127.4, 126.1, 122.2, 60.7, 56.6, 29.8, 26.0, 24.4. ESI-MS (m/z): 679.4 (M + H+, 100%).FeII(CDA-BQA*) (5): Ligand ± CDA-BQA (14.2 mg, 0.02 mmol) and Fe(CF3SO3)2 (7.4 mg, 0.02 mmol) were dissolved in dry acetonitrile and mixed. The reaction vessel was placed in a tank with dry diethyl ether for vapour diffusion. The complex preparation was performed in a drybox in an atmosphere of argon. After 1 day, crystals suitable for single crystal X-ray diffraction were obtained. UV-Vis [MeCN = acetonitrile] [λmax, nm logε] = 203 (5.03), 231 (4.78), 307 (4.13). FT-IR bands (KBr pellet cm−1): 3429 m, 3068 w, 2933 w, 2859 w, 1701 s, 1653 s, 1600 w, 1279 s, 1166 s, 1029 s, 784 w, 667 m, 638 m, 522 w. Anal Calcd for C48H42F6FeN6O6S2: C, 55.82; H, 4.10; N, 8.14. Found: C, 55.79; H, 4.15; N, 8.19. X-ray: Chemical formula: C50H45F6FeN7O6S2, Formula weight: 1073.90, Crystal system: orthorhombic, Space group: Cmca, a (Å): 19.7874(9), b (Å): 42.5557(15), c (Å): 12.4013(4), Volume (Å3): 10442.7(7), Z: 8, Calc. density (g cm−1): 1.366, Temperature (K): 293(2), Abs. coeff. (mm−1): 3.715, F (0 0 0): 4432, Obs. reflections: 5532, Goodness-of-fit: 1.055, R1: 0.0761, wR2: 0.2287 (w=1⁄[σ2(Fo2)+(0.1721P)2+1.4205P] and P = (F +2F2)/3). CCDC deposit number 2082080 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (accessed on 30 April 2021) (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033) (Table S1).Catalytic oxidation of ethylbenzene was carried out under thermostatic (273 K) conditions. In a typical reaction, 500 µL of TBHP (diluted from 70% TBHP) solution in CH3CN was delivered by a syringe pump in air to a stirred solution (1 mL) of 6 catalysts, and ethylbenzene inside a vial. The final concentrations were 2 mM catalyst 6, 50 mM (100, 200 mM) oxidant, and 500 mM substrate. The mixture was stirred for 15 min. The products were identified by GC analysis, and their yields were determined by comparison with authenticcompounds using bromobenzene (25.00 × 103 M) as an internal standard in the reactions.Complex 6 (2.00 × 103 M) was dissolved in acetonitrile (2 mL), then iodosobenzene (16.00 × 10−3 M) and ethylbenzene (1500 × 10−3 M) were added to the solution in CH3CN at 273 K. The mixture was stirred for 3 h and the products were identified by GC analysis, and their yields were determined by comparison with authenticcompounds using bromobenzene (4.00 × 103 M) as an internal standard in the reactions. Enantiomeric excess was determined with GC analysis on a chiral column: (ee = [R] − [S])/([R] + [S]).Catalytic oxidation of flavanone was carried out under thermostatic (298 K) conditions. In a typical reaction, 5.8 mg 2 (5 mM) and 33.6 mg flavanone (100 mM) was dissolved in 1 mL CH3CN, and 169 mg mCPBA (500 mM) in 500 µL CH3CN was delivered by syringe pump to a stirred solution. After syringe pump addition (5 min the solution was stirred for 5 min and a known amount of PhBr (0.315 mmol) was added as an internal standard. The ironcomplex was removed by passing the reaction mixture through a silicacolumn followed by elution with ethyl acetate. The products (1,3-dione (D) and flavone) were identified by GC/MS and confirmed by comparison with authentic samples. Flavone is commercially available and it was purchased from Sigma-Aldrich. 1-(2-hydroxy-phenyl)-3-phenyl-propane-1,3-dione (D): o-Benzoyloxyacetophenone has been prepared by the action of benzoyl chloride on a pyridine solution of o-hydroxyacetophenone. Its rearrangement to 1-(2-hydroxy-phenyl)-3-phenyl-propane-1,3-dione (D) by alkali has been described [57]. (F) m/z: 222 (85.92%), 194 (58.9%), 165 (18%) 120 (100%), 92 (95,2%). 63 (35.3%). 1,3-dione (D): m/z: 240 (15.1%), 223 (8.3%), 121 (25.2%), 120 (7.3%), 106 (7.2%), 105 (100%), 77 (30%), 69 (6.0%), 65 (9.3%), 51 (4.5%), 39 (8.3%).Stoichiometric reactions were carried out under thermostaticconditions at 10 °C in 1 cm quartz cuvettes. In a typical experiment, [FeII(Bn-TPEN)(CH3CN)]2+ (2 × 10−3 M) was dissolved in acetonitrile(CH3CN-TFE) (2.0 cm3), then iodosobenzene (4 × 10−3 mM) was added to the solution. The mixture was stirred for 50 min then excess iodosobenzene was removed by filtration. Flavanone (50 mM) was added to the solution and the reaction was monitored by UV-Vis spectrophotometer (Agilent 8453) at 739 nm (ε = 450 M−1 cm−1).
4. Conclusions
In conclusion, we previously found that N4Py-based iron(II)complexes capable of carrying out 2,3-desaturation of flavanone via 2-hydroxyflavanone intermediate formation can act as a functional flavone synthase model. As a continuity of this study, efforts have been made to enhance the catalytic activity by the use of TPEN-type ligands and investigate the role and effect of the metalcofactor through manganese and ironcomplexes with the same ligand framework. Comparing the reactions of [FeIV(O)(Bn-TPEN)]2+ (9) and [MnIV(O)(Bn-TPEN)]2+ (10) towards flavanone under the same conditions, a 3.5-fold difference in reaction rate was observed in favour of iron, and this value is three orders of magnitude higher than that was observed for the previously published [FeIV(O)(N2Py2Q*)]2+ species. The relative reactivity of oxoiron(IV) complexes is in the order of [FeIV(O)(CDA-BPA*)]2+ (11) > [FeIV(O)(Bn-TPEN)]2+ (9) > [FeIV(O)(N2Py2Q*)]2+ > [FeIV(O)(N4Py)]2+ > [FeIV(O)(N4Py*)]2+ (7), which is consistent with our catalytic results, and shows that addition of cyclohexanediamine as the chiral element successfully lead to increase in the catalytic activity. Although we have reported the first example of efficient flavanone oxidation by iron and manganesecomplexes, detailed studies are underway to elucidate the mechanisms of flavone formation.
Authors: Eric J Klinker; József Kaizer; William W Brennessel; Nathaniel L Woodrum; Christopher J Cramer; Lawrence Que Journal: Angew Chem Int Ed Engl Date: 2005-06-13 Impact factor: 15.336
Authors: Ramona Turcas; Balázs Kripli; Amr A A Attia; Dóra Lakk-Bogáth; Gábor Speier; Michel Giorgi; Radu Silaghi-Dumitrescu; József Kaizer Journal: Dalton Trans Date: 2018-10-23 Impact factor: 4.390
Authors: Carole Duboc-Toia; Stéphane Ménage; Raymond Y. N. Ho; Lawrence Que; Claude Lambeaux; Marc Fontecave Journal: Inorg Chem Date: 1999-03-22 Impact factor: 5.165
Authors: Dóra Lakk-Bogáth; Róbert Csonka; Gábor Speier; Marius Réglier; A Jalila Simaan; Jean-Valère Naubron; Michel Giorgi; Károly Lázár; József Kaizer Journal: Inorg Chem Date: 2016-09-26 Impact factor: 5.165
Authors: Stefan Martens; Gert Forkmann; Lothar Britsch; Frank Wellmann; Ulrich Matern; Richard Lukacin Journal: FEBS Lett Date: 2003-06-05 Impact factor: 4.124